MK-9470
PET tracer of the human CB1 receptor, inverse agonist (IC50 0.7 nM).
C₂₉H₃₂FN₃O₃
CAS 947371-30-4
- Family
- ECS pharmacological toolAntagonist or inverse agonist
- Molar mass
- 489.60 g/mol
Updated on
In plain terms
MK-9470 is used to photograph CB1 receptors in a living brain. Labelled with a short-lived radioactive atom, it binds to these receptors and makes their distribution visible to a camera. It is a research imaging tool, not a treatment.
Receptors and activity
Target network
- Blocks or inhibits
The lower the cited value, the closer the target sits to MK-9470: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of MK-9470.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1Inverse agonistIC50 = 0.7 nM · human86 out of 100
Burns et al., Proc Natl Acad Sci U S A 2007 (new tab) · IC50 at human CB1 (abstract; preparation not specified); selective and high-affinity; inverse agonist; fluorine-18 labelled for PET
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of MK-9470, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
[18F]MK-9470 is a positron emission tomography (PET) tracer of the CB1 receptor, developed for human brain imaging. Described in 2007 by Burns and colleagues, it is a selective high-affinity inverse agonist (human IC50 0.7 nM) labelled with fluorine-18. In autoradiography on rhesus monkey brain its binding follows the known distribution of CB1; in PET in monkeys, brain uptake is high, the ratio of total to nonspecific binding reaches 4 to 5 in the putamen, and the signal is blocked by pretreatment with the inverse agonist MK-0364 and reversible by displacement. In volunteers the tracer behaves like in monkeys, with a test-retest variability of 7%, and oral MK-0364 given to healthy young men produced a dose-related reduction in binding reflecting CB1 occupancy by the drug (Burns et al. 2007). In 50 healthy volunteers aged 18 to 69, CB1 binding increased with age in women only (Van Laere et al. 2008). In 10 chronic cannabis users examined within a week of last use, CB1 availability was 11.7% lower overall than in 10 age-matched controls (Ceccarini et al. 2015). The tracer serves research; it has no therapeutic purpose.
Key sources.
- Burns HD et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A, 2007 (new tab)PMID 17535893
- Van Laere K et al. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET. Neuroimage, 2008 (new tab)PMID 18077184
- Ceccarini J et al. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol, 2015 (new tab)PMID 24373053
- PubChem, MK-9470, CID 11488705 (identifiers and properties) (new tab)
History
- Source
- An entirely synthetic compound with no natural occurrence. Its useful form, [18F]MK-9470, is labelled with fluorine-18, a short-lived radionuclide produced in a cyclotron (Burns et al. 2007).
Origin
Research tool
No biological pathway: MK-9470 is a synthetic compound of the acyclic amide class, unrelated to the plant cannabinoid pathway.
Legal framework
- European Union
The substance is not listed in the Annex to Council Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which lists the new psychoactive substances controlled at European Union level; control is a matter for national law. It is not listed in the schedules of the 1971 Convention on Psychotropic Substances (INCB Green List, 36th edition, 2025, text reviewed). No marketing authorisation was found.
- France
Not classified: MK-9470 is not on the ANSM consolidated list of narcotics (updated 16/02/2026) and this acyclic amide falls within none of the generic families of that list. In its radiolabelled form, its use falls under imaging research and the rules applying to radiopharmaceuticals and radiation protection.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
ECS pharmacological tool › Antagonist or inverse agonist
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Burns HD et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A, 2007 (new tab)PMID 17535893
- Van Laere K et al. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET. Neuroimage, 2008 (new tab)PMID 18077184
- Ceccarini J et al. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users. Addict Biol, 2015 (new tab)PMID 24373053
- PubChem, MK-9470, CID 11488705 (identifiers and properties) (new tab)
Identifiers
Names
- IUPAC name
- N-[(2S,3S)-3-(3-cyanophenyl)-4-[4-(2-fluoroethoxy)phenyl]butan-2-yl]-2-methyl-2-[(5-methyl-2-pyridinyl)oxy]propanamide
- Other names
- [18F]MK-9470 · MK 9470
Identifiers
- Formula
- C₂₉H₃₂FN₃O₃
- CAS
- 947371-30-4
- PubChem CID
- 11488705(new tab)
- InChIKey
- XIYPJXKEMLKFMD-HFZDXXHNSA-N
- SMILES
- CC1=
CN= C(C= C1) OC(C) (C) C(= O) N[C@@H] (C) [C@@H] (CC2= CC= C(C= C2) OCCF) C3= CC= CC(= C3) C#N
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.